Neuroleptic Dosing in Chronic Schizophrenia: A 10-Year Follow-up

Abstract

A considerable number of patients with schizophrenia appear to receive progressively higher neuroleptic doses over the course of their illness, despite a lack of empirical data to support such an approach. Results are discussed in terms of current dosing recommendations and factors influencing dose changes.